Elekta has received FDA clearance for its Fraxion head frame. The head frame is used in stereotactic radiation therapy of intracranial tumors where it helps ensure accuracy and precision.
The Fraxion integrates multiple cranial immobilization options in a single solution.
From the press release:
Fraxion head fixation can be used for virtually any patient. The patient can be immobilized with a thermoplastic mask, with the vacuum mouthpiece, or even a combination of both systems. Precise repositioning is possible as the system is directly connected to the treatment table and micro adjustments are possible via easily accessible screws for full 6D patient positioning.
The partial and full head thermoplastic masks provide alternative immobilization options for non-invasive setup, without compromising accuracy. Combining the thermoplastic mask with the vacuum mouthpiece increases flexibility in setup options, allowing optimal setup based on the patient’s needs.
Press release: Elekta receives FDA 510(k) clearance for Fraxion…
Product page: Elekta Fraxion…
